IL6 and neoplasm: Furthermore, Huang et al. [76] discovered that the active components of ANs can lower the levels of interleukin-6 (IL-6) in tumor cells, increase the levels of the tumor suppressor factor p53, induce tumor cell apoptosis, and thus potentially prevent tumor development.